Matching slides 60,568
Current window 37,321-37,350
Pages 2,019
Rows per page 30
Component: Tableclear collectionreset all

Component

37,321-37,350 of 60,568

filter-aware
34
The slide includes a background image of a person, likely a stylistic choice for the deck.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
17
The table uses 'X' marks to indicate feature presence and specific clinical trial/dosing status for the Immunovant franchise.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
05
The table uses color coding to distinguish between vaccine strains (green) and non-vaccine strains (blue).SAB Biotherapeutics | Results Presentation Deck | 12 slides · SAB Biotherapeutics
Regulatory filing Investor relations 1 hit
05
The table highlights 2022 data with a light blue background column. Includes a disclaimer about restated 2021 data and exclusion of cash flow hedge effects.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
06
Includes a disclaimer about restated 2021 data and exclusion of cash flow hedge effects.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
Includes a highlight box around the 2022 column. Data is in Euro MM.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
The table compares 2022 and 2021 June YTD figures with percentage changes.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
The table includes a breakdown of Net Invested Capital and Financial Sources, with a secondary section calculating Adjusted Net Debt.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations 1 hit
10
The table includes a footnote regarding the exclusion of cash flow hedge effects for performance analysis.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations 1 hit
11
Includes a disclaimer regarding the exclusion of cash flow hedge effects and restated 2021 data.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations 1 hit
12
Includes a footnote regarding the exclusion of cash flow hedge effects and restatement of 2021 data.Salvatore Ferragamo | Results Presentation Deck | 13 slides · Salvatore Ferragamo
Conference presentation Investor relations 1 hit
05
The table uses a waterfall-style logic to explain the variance between previous and updated outlooks.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
06
Includes notes on fiscal year end, product level view, and Codecademy inclusion.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations Beat · What Is1 hit
07
Proforma values include Codecademy starting April 5th of each year. Fiscal years end January 31.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations Beat · What Is1 hit
10
The table uses Treasury Stock Method (TSM) for calculations.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations 1 hit
11
Includes reconciliation of operating loss, adjusted net income, and adjusted EBITDA.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations 1 hit
12
The table reconciles Skillsoft Corp. GAAP results to a combined view including revenue adjustments.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations 1 hit
13
Includes footnotes explaining the adjustments for Global Knowledge, Skillsoft, and Codecademy.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations 1 hit
14
Includes footnotes explaining GAAP results of Skillsoft, non-GAAP revenue adjustments, and Codecademy proforma adjustments.Skillsoft | Results Presentation Deck | 14 slides · Skillsoft
Conference presentation Investor relations 1 hit
05
The slide details a specific bond indenture modification strategy to improve credit metrics.SkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
07
The slide uses red dots to indicate achievement status for various line items.SkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
16
RP2D (Recommended Phase 2 Dose) is highlighted at DL 3.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
17
The table categorizes adverse events into Hematologic, On Target/On Tumor, On Target/Off Tumor, and Other, with a specific highlight on the RP2D (Recommended Phase 2 Dose) column.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
18
Waterfall plot is a standard clinical trial visualization for tumor response.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
20
The slide presents Kaplan-Meier curves for Progression-Free Survival and Overall Survival alongside a comparative table of historical study data.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
24
Data shows patient-specific longitudinal tracking of transgene copies/µg gDNA.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
33
The chart uses horizontal bars to represent the development stage of each program.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
07
The slide presents a summary of preclinical efficacy and safety data alongside a table demonstrating high selectivity against other kinases.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
10
The table displays counts and percentages of subjects experiencing specific adverse events. 'MAD' stands for Multiple Ascending Dose.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
12
The slide includes a disclaimer that cross-study comparisons are unreliable due to differences in study design.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit